the antiestrogens tamoxifen ( tamoxifen-citrate ) and zuclomiphine 2- [ p- ( chloro-1,2-diphenyl-vinyl ) phenoxyl ] citrate ) were potent inhibitors ( greater than or equal to 50 % ) of the estrogen-stimulated association of both er and type ii sites with the matrix .
C0039286
tamoxifen
C0079589
tamoxifen-citrate